ResearcherSaint John's Health CenterNo recent work listed

Melanie R. Goldfarb

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3929-0354; OpenAlex author ID A5004011358. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 3)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 5

Papers, trials and grants by year

2022: 1 paper · 2023: 2 papers

Papers 3

Validating biologic age in selecting elderly patients with pancreatic cancer for surgical resection. Last author DOI 10.1002/jso.27121 ↗
Evolving management of early stage pancreatic adenocarcinoma in older patients. Last author DOI 10.1016/j.amjsurg.2022.07.026 ↗
Neoadjuvant chemotherapy improves outcomes in resectable pancreatic adenocarcinoma. Last author DOI 10.1016/j.sipas.2022.100136 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wade O. Christopher · 2 shared papers, 2022–2023 · strength 0.34
- Paper Evolving management of early stage pancreatic adenocarcinoma in older patients. DOI 10.1016/j.amjsurg.2022.07.026 ↗
- Paper Neoadjuvant chemotherapy improves outcomes in resectable pancreatic adenocarcinoma. DOI 10.1016/j.sipas.2022.100136 ↗
Sean P. Nassoiy · 2 shared papers, 2022–2023 · strength 0.34
- Paper Evolving management of early stage pancreatic adenocarcinoma in older patients. DOI 10.1016/j.amjsurg.2022.07.026 ↗
- Paper Neoadjuvant chemotherapy improves outcomes in resectable pancreatic adenocarcinoma. DOI 10.1016/j.sipas.2022.100136 ↗
Ronald Wolf · 1 shared paper, 2023 · strength 0.18
- Paper Validating biologic age in selecting elderly patients with pancreatic cancer for surgical resection. DOI 10.1002/jso.27121 ↗
Anthony Joseph Scholer · 1 shared paper, 2023 · strength 0.18
- Paper Validating biologic age in selecting elderly patients with pancreatic cancer for surgical resection. DOI 10.1002/jso.27121 ↗
Zeljka Jutric · 1 shared paper, 2023 · strength 0.18
- Paper Validating biologic age in selecting elderly patients with pancreatic cancer for surgical resection. DOI 10.1002/jso.27121 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.